Evidence map›Paper›PMID 41613197›Full record

ArticleJDS communications2025

Validation of a rapid on-farm culture system for group classification of clinical mastitis-causing pathogens.

Fernando J Guardado Servellon, David L Renaud, Bruno Joaquin Paredes Osorio, Kelsey L Spence, Trevor J DeVries, Rita Couto Serrenho

Abstract read
In one paragraph

Article in JDS communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Detection ofAnimals : an open access journal from MDPI · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fernando J Guardado ServellonPopulation Medicine, University of Guelph, Guelph, ON N1G 2W1, Canada.
David L RenaudPopulation Medicine, University of Guelph, Guelph, ON N1G 2W1, Canada.
Bruno Joaquin Paredes OsorioEldale Veterinary Clinic, Elmira, ON N3B 1N3, Canada.
Kelsey L SpencePopulation Medicine, University of Guelph, Guelph, ON N1G 2W1, Canada.
Trevor J DeVriesAnimal Biosciences, University of Guelph, Guelph, ON N1G 2W1, Canada.
Rita Couto SerrenhoPopulation Medicine, University of Guelph, Guelph, ON N1G 2W1, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this diagnostic accuracy study was to compare the use of a rapid tube test system (MastDecide [MD]; Quidee GmbH, Homberg, Germany) to aerobic milk culture for group classification of mastitis pathogens in dairy cattle. A total of 204 milk samples from cows with clinical mastitis (CM) were collected across 60 dairy herds in Ontario, Canada. Samples were collected by dairy producers and their staff and transported refrigerated to the University of Guelph Animal Health Laboratory (Guelph, ON, Canada) on the day of collection. Each sample was tested via MD (gram-positive, gram-negative, or "no growth") and via aerobic milk culture followed by MALDI-TOF (reference method [RM]). The MD and RM results were interpreted at 14 and 24 h after incubation, respectively. An additional assessment was performed regarding the accuracy of intramammary antibiotic treatment decisions (gram-positive: to treat; gram-negative and "no growth" samples: not to treat). Test performance characteristics (overall accuracy, sensitivity [Se], specificity [Sp], and positive [PPV] and negative predictive value [NPV]) as well as Cohen's kappa coefficient (κ) were calculated. The RM results were classified as gram-positive (n = 107, 53%), gram-negative (n = 20, 10%), "no growth" (n = 51, 25%), other pathogens (n = 21, 10%), and mixed growth (gram-positive and gram-negative; n = 5, 3%). The Se of the MD test was 58% (95% CI: 47%-67%), 40% (19%-64%), and 61% (50%-72%) for gram-positive, gram-negative, and "no growth," respectively. The Sp of the MD test was 73% (63%-81%), 84% (78%-89%), and 75% (66%-82%) for gram-positive, gram-negative, and "no growth," respectively. The PPV of the MD test was 68% (57%-78%), 22% (10%-39%), and 62% (50%-73%) for gram-positive, gram-negative, and "no growth," respectively; and the NPV was 63% (54%-72%), 93% (87%-96%), and 74% (65%-82%) for gram-positive, gram-negative, and "no growth," respectively. The overall test accuracy for Gram stain classification analysis was 57%, with a κ of 0.30. Regarding intramammary antibiotic treatment, the MD test yielded a correct decision relative to the RM for 65% of the cases. Using this on-farm test as a primary guide in CM treatment decisions should be approached with caution, as the risk of false negatives may affect the ability to effectively treat CM cases.

Identifiers

PMID41613197
PMCPMC12848257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.